Fluorescence In Situ Hybridization Imaging Systems Market Size, Share & Trends Report

Fluorescence In Situ Hybridization Imaging Systems Market Size, Share & Trends Analysis Report By Product (Instruments), By Application (Cancer Diagnosis), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-653-0
Number of Report Pages: 120
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Fluorescence In Situ Hybridization Imaging Systems Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Million)
  3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
  3.4. Fluorescence In Situ Hybridization Imaging Systems Analysis Tools
  3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and Social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Fluorescence In Situ Hybridization Imaging Systems Market: Product Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Fluorescence In Situ Hybridization Imaging Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  4.3. Instruments
  4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.2. Microscopes
  4.3.2.1. Microscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.3. Automated cell analyzers
  4.3.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.4. Others
  4.3.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4. Consumables & Accessories
  4.4.1. Consumables & Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5. Services
  4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.6. Software
  4.6.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Fluorescence In Situ Hybridization Imaging Systems: Application Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Fluorescence In Situ Hybridization Imaging Systems Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  5.3. Cancer Diagnosis
  5.3.1. Cancer Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.3.2. Lung Cancer
  5.3.2.1. Lung Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.3.3. Breast Cancer
  5.3.3.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.3.4. Others
  5.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.4. Genetic Disease Diagnosis
  5.4.1. Genetic Disease Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.5. Others
  5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Fluorescence In Situ Hybridization Imaging Systems: End Use Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Fluorescence In Situ Hybridization Imaging Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  6.3. Diagnostic Laboratories
  6.3.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4. Research & Academic Institutes
  6.4.1. Research & Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5. Others
  6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Fluorescence In Situ Hybridization Imaging Systems Market: Regional Estimates & Trend Analysis
  7.1. Fluorescence In Situ Hybridization Imaging Systems Share, By Region, 2023 & 2030 (USD Million)
  7.2. North America
  7.2.1. North America Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.2. U.S.
  7.2.2.1. U.S. Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.3. Canada
  7.2.3.1. Canada Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.4. Mexico
  7.2.4.1. Mexico Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3. Europe
  7.3.1. Europe Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.2. U.K.
  7.3.2.1. U.K. Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.3. Germany
  7.3.3.1. Germany Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.4. France
  7.3.4.1. France Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.5. Italy
  7.3.5.1. Italy Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.6. Spain
  7.3.6.1. Spain Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.7. Denmark
  7.3.7.1. Denmark Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.8. Sweden
  7.3.8.1. Sweden Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.9. Norway
  7.3.9.1. Sweden Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4. Asia Pacific
  7.4.1. Asia Pacific Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.2. Japan
  7.4.2.1. Japan Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.3. China
  7.4.3.1. China Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.4. India
  7.4.4.1. India Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.5. South Korea
  7.4.5.1. South Korea Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.6. Thailand
  7.4.6.1. Thailand Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5. Latin America
  7.5.1. Latin America Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.2. Brazil
  7.5.2.1. Brazil Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.3. Argentina
  7.5.3.1. Argentina Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6. Middle East and Africa
  7.6.1. Middle East and Africa Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.2. South Africa
  7.6.2.1. South Africa Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.3. Saudi Arabia
  7.6.3.1. Saudi Arabia Fluorescence In Situ Hybridization Imaging Systems and Forecasts, 2018 - 2030 (USD Million)
  7.6.4. UAE
  7.6.4.1. Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.5. Kuwait
  7.6.5.1. Kuwait Fluorescence In Situ Hybridization Imaging Systems Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
  8.1. Recent Developments & Impact Analysis by Key Market Participants
  8.2. Company Categorization
  8.3. Company Heat Map Analysis
  8.4. Company Profiles
  8.4.1. Euroclone SpA
  8.4.1.1. Participant’s Overview
  8.4.1.2. Financial Performance
  8.4.1.3. Product Benchmarking
  8.4.1.4. Recent Developments/ Strategic Initiatives
  8.4.2. TissueGnostics GmbH
  8.4.2.1. Participant’s Overview
  8.4.2.2. Financial Performance
  8.4.2.3. Product Benchmarking
  8.4.2.4. Recent Developments/ Strategic Initiatives
  8.4.3. Agilent Technologies, Inc.
  8.4.3.1. Participant’s Overview
  8.4.3.2. Financial Performance
  8.4.3.3. Product Benchmarking
  8.4.3.4. Recent Developments/ Strategic Initiatives
  8.4.4. Abnova Taiwan Corp
  8.4.4.1. Participant’s Overview
  8.4.4.2. Financial Performance
  8.4.4.3. Product Benchmarking
  8.4.4.4. Recent Developments/ Strategic Initiatives
  8.4.5. BioGenex Laboratories Inc
  8.4.5.1. Participant’s Overview
  8.4.5.2. Financial Performance
  8.4.5.3. Product Benchmarking
  8.4.5.4. Recent Developments/ Strategic Initiatives
  8.4.6. Leica Biosystems Nussloch GmbH
  8.4.6.1. Participant’s Overview
  8.4.6.2. Financial Performance
  8.4.6.3. Product Benchmarking
  8.4.6.4. Recent Developments/ Strategic Initiatives
  8.4.7. Bio-View Ltd
  8.4.7.1. Participant’s Overview
  8.4.7.2. Financial Performance
  8.4.7.3. Product Benchmarking
  8.4.7.4. Recent Developments/ Strategic Initiatives
  8.4.8. Thermo Fisher Scientific, Inc.
  8.4.8.1. Participant’s Overview
  8.4.8.2. Financial Performance
  8.4.8.3. Product Benchmarking
  8.4.8.4. Recent Developments/ Strategic Initiatives
  8.4.9. MetaSystems Probes GmbH
  8.4.9.1. Participant’s Overview
  8.4.9.2. Financial Performance
  8.4.9.3. Product Benchmarking
  8.4.9.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.